Demonising Justin Gatlin
13th September 2015
Cycling Australia has issued a four year ban to Michael Fitzgerald for use of 14 prohibited substances and methods in a period ranging over five years, a sanction published by the Australian Sports Anti-Doping Authority (ASADA) has revealed. The 14 Anti-Doping Rule Violations (ADRVs), which took place ‘on or between 7 December 2009 and 31 March 2015’, are understood to be the largest number ever confirmed in a single doping sanction.
Fitzgerald was sanctioned with Use and Attempted Use of Prohibited Substances, Possession of Prohibited Substances and Attempted Use of a Prohibited Method. The substances and methods involved were: Erythropoietin; Clomifene citrate; Anastrozole; Testosterone Enantate; Testosterone Propionate; Mesterolone; Human Chorionic Gonadotrophin; Testosterone (Sustanon 250); Tetracosactide and Tetracosactrin; Tamoxifen citrate; DHEA; Vasopressin; blood doping, specifically the use of autologous red blood cell products; intravenous infusion of Vitamin C and a blood plasma infusion of more than 50ml per six hour period. Fitzgerald’s results from December 2009 to 25 May 2018 will be annulled.
Last year, Italian bodybuilder Giuseppe Ippolito returned an adverse analytical finding (AAF) for 14 different substances from a single sample at the Italian Federation of Bodybuilding (IFBB) Championships in Rome on 2 July. As no record exists of a sanction issued to Ippolito, it is assumed that his case is still in progress.
A year earlier, a sample given by Claudio Stella at the 2016 North Italian Bodybuilding Championships returned an AAF for 20 prohibited substances. The Italian Olympic Committee (CONI) confirmed that 11 bodybuilders had tested positive at the event. Stella was later sanctioned with a four year ban, however CONI did not provide further details about whether he had been sanctioned for all 20 AAFs.
• Athlete leaders cite earlier concerns raised over independence and transparency • Additional information reveals...
• Brazilian club Atletico Paranaense announced that an internal investigation has confirmed that adverse analytical...
The Medical Practitioners Tribunal Service (MPTS) has yet to agree a new hearing date with...